Semaglutide targets one receptor (GLP-1), while tirzepatide targets two (GIP + GLP-1)
Peptide self-administration options include injections, oral capsules, nasal sprays, and topical creams
US-based with 99%+ HPLC-verified purity, batch-specific COAs from third-party laboratories, and 5-star Trustpilot from thousands of verified customers
There was no change in cognitive parameters in the follow-up assessment compared to controls [325]
Phase 2 trial results, published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023), demonstrated that participants receiving the highest dose of retatrutide lost an average of approximately 24% of their body weight over 48 weeks a finding that attracted considerable attention from the medical and scientific communities
One antioxidant in particular your master antioxidant has the power to help you age well